Fast Market Research recommends "Light Sciences Oncology, Inc. - Product Pipeline Review - 2012" from Global Markets Direct, now available
Boston, MA -- (SBWIRE) -- 01/18/2013 -- Global Market Direct's pharmaceuticals report, "Light Sciences Oncology, Inc. - Product Pipeline Review - 2012" provides data on the Light Sciences Oncology, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Light Sciences Oncology, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Light Sciences Oncology, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.
View Full Report Details and Table of Contents
- Light Sciences Oncology, Inc. - Brief Light Sciences Oncology, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Light Sciences Oncology, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Light Sciences Oncology, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Light Sciences Oncology, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to Get this Report
- Evaluate Light Sciences Oncology, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Light Sciences Oncology, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Light Sciences Oncology, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Light Sciences Oncology, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Light Sciences Oncology, Inc. and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Gastrointestinal Tract Cancer - Pipeline Review, H2 2012
- Pancreatic Cancer - Pipeline Review, H1 2012
- Hepatocellular Carcinoma - Pipeline Review, H1 2012
- LG Life Sciences, Ltd. - Product Pipeline Review - 2012
- Amorfix Life Sciences Ltd. - Product Pipeline Review - 2012
- Human Genome Sciences, Inc. - Product Pipeline Review - 2012
- ProMetic Life Sciences Inc. - Product Pipeline Review - 2012
- Gilead Sciences, Inc. - Product Pipeline Review - 2012
- ZIOPHARM Oncology, Inc. - Product Pipeline Review - 2012
- Age Related Macular Degeneration - Pipeline Review, H1 2012
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)